Search results for "CSF"

showing 10 items of 48 documents

CSF homocysteine levels in Amyotrophic Lateral Sclerosis

2008

CSF ALS
researchProduct

CSF HOMOCYSTEINE LEVELS IN AMYOTROPHC LATERAL SCLEROSIS

2008

CSF HOMOCYSTEINEA MYOTROPHC LATERAL SCLEROSISSettore MED/26 - Neurologia
researchProduct

Tietojärjestelmän käyttöönoton kriittiset menestystekijät logistiikkakeskuksessa : tapaustutkimus

2017

Liiketoiminta muuttuu jatkuvasti kustannustehokkaammaksi ja nopeatempoisemmaksi. Toimintoja tehostetaan ja säästöjä pyritään löytämään kaikista mahdollisista kohteista. Tietojärjestelmiä kehitetään helpottamaan ja nopeuttamaan liiketoimintaa. Yritykset investoivatkin runsaasti uusiin tietojärjestelmiin. Tietojärjestelmien ja varsinkin ERP-järjestelmien käyttöönotot ovat kuitenkin vaativia projekteja. ERP-järjestelmä on integroitu moduuleista koostuva tietojärjestelmä, joka käyttää organisaation yhteisiä tietokantoja. Kohdeyrityksessä eli keskisuuressa logistiikkakeskuksessa oli haasteita aiemman tietojärjestelmän käyttöönoton yhteydessä, joten nyt lähdettiin laatimaan ohjeistusta tulevan ER…

CSFtoiminnanohjausjärjestelmätkäyttöönottoERPtietojärjestelmät
researchProduct

High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients

2020

Background: Progressive multifocal leukoencephalopathy (PML) can in rare cases occur in natalizumab-treated patients with high serum anti-JCPyV antibodies, hypothetically due to excessive blockade of immune cell migration. Objective: Immune cell recruitment to the central nervous system (CNS) was assessed in relapsing-remitting multiple sclerosis (RRMS) patients stratified by low versus high anti-JCPyV antibody titers as indicator for PML risk. Methods: Cerebrospinal fluid (CSF) cell counts of 145 RRMS patients were quantified by flow cytometry. Generalized linear models were employed to assess influence of age, sex, disease duration, Expanded Disability Status Scale (EDSS), clinical/radiol…

CellCell Countprogressive multifocal leukoencephalopathycerebrospinal fluidMultiple sclerosis03 medical and health sciencesMultiple Sclerosis Relapsing-Remitting0302 clinical medicineNatalizumabCerebrospinal fluidmedicineHumansJCV index030304 developmental biology0303 health sciencesbiologybusiness.industryNatalizumabMultiple sclerosisProgressive multifocal leukoencephalopathyLeukoencephalopathy Progressive MultifocalJCPyVmedicine.diseaseJC VirusCSF cell countstissue-resident memory cellsBlockadeclinical activityTitermedicine.anatomical_structureNeurologyImmunologybiology.proteinNeurology (clinical)AntibodybusinessOriginal Research Papers030217 neurology & neurosurgerymedicine.drugMultiple Sclerosis Journal
researchProduct

Instrument transfer as knowledge transfer in neurophysiology: François Magendie's (1783-1855) early attempts to measure cerebrospinal fluid pressure.

2007

Francois Magendie's (1783-1855) experimental model for measuring blood pressure in animals, which he developed in 1838, had a major impact on French physiology in the nineteenth century, especially upon Etienne-Jules Marey (1830-1904) in Paris. In due course it was also adopted by other European investigators, such as the Leipzig physiologist Carl Ludwig (1816-1895), and by clinicians who developed it into a major measuring tool. Historians of science, however, have paid hardly any attention to Magendie's further laboratory investigations conducted with the assistance of Jean-Louis Marie Poiseuille's (1799-1869) sphygmometre (blood pressure meter). After having used the apparatus to conduct…

Cognitive scienceExperimental modelbusiness.industryGeneral NeuroscienceNeurophysiologyHistory 19th CenturyNeurophysiologyVentricular systemHistory 18th CenturyCsf flowKnowledgeHistory and Philosophy of ScienceCerebrospinal Fluid PressureMedicineHumansNeurology (clinical)Cerebrospinal fluid pressureDiffusion of InnovationbusinessNeuroscienceKnowledge transferBrain functionIntracranial pressureCerebrospinal FluidJournal of the history of the neurosciences
researchProduct

Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 i…

2012

Cancer vaccines have always been a subject of gene therapy research. One of the most successful approaches has been working with genetically modified tumor cells. In this study, we describe our approach to achieving an immune response against a murine melanoma model, employing B16 tumor cells expressing GM-CSF and B7.2. Wild B16 cells were injected in C57BL6 mice to cause the tumor. Irradiated B16 cells transfected with GM-CSF, B7.2, or both, were processed as a preventive and therapeutic vaccination. Tumor volumes were measured and survival curves were obtained. Blood samples were taken from mice, and IgGs of each treatment group were also measured. The regulatory T cells (Treg) o…

Cytotoxicity Immunologicnon-viralHealth Toxicology and MutagenesisGenetic enhancementMelanoma Experimentallcsh:MedicineToxicologyTransfectionT-Lymphocytes RegulatoryImmunoglobulin GArticleMiceImmune systemCell Line TumormedicineAnimalsbiologylcsh:RGene Transfer TechniquesCancerGranulocyte-Macrophage Colony-Stimulating FactorGM-CSFTransfectionGenetic Therapymedicine.diseaseSurvival Analysisgene therapyGenetically modified organismVaccinationMice Inbred C57BLGranulocyte macrophage colony-stimulating factorB7.2Immunoglobulin GImmunologybiology.proteinB7-2 AntigenNeoplasm Transplantationcancer vaccinesmedicine.drugToxins
researchProduct

Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus

2021

In adult cornu ammonis hippocampi, erythropoietin (EPO) expression drives the differentiation of new neurons,independent of DNA synthesis, and increases dendritic spine density. This substantial brain hardwareupgrade is part of a regulatory circle: during motor-cognitive challenge, neurons experience ‘‘functional’’hypoxia, triggering neuronal EPO production, which in turn promotes improved performance. Here, weshow an unexpected involvement of resident microglia. During EPO upregulation and stimulated neurodifferentiation,either by functional or inspiratory hypoxia, microglia numbers decrease. Treating mice with recombinanthuman (rh)EPO or exposure to hypoxia recapitulates these changes and…

Dendritic spineQH301-705.5Mice TransgenicBiologyHippocampusGeneral Biochemistry Genetics and Molecular BiologyMice03 medical and health sciences0302 clinical medicineDownregulation and upregulationrecombinant human EPOhemic and lymphatic diseasesmedicineAnimalsBiology (General)Hypoxia BrainReceptorErythropoietin030304 developmental biology0303 health sciencesMicrogliahypoxiaPyramidal CellsNeurogenesisneurodifferentiationCell DifferentiationHypoxia (medical)CSF1Rneurogenesismedicine.anatomical_structurenervous systemErythropoietinApoptosisIL-34Microgliamedicine.symptomNeuroscience030217 neurology & neurosurgerymedicine.drug
researchProduct

" Effectiveness of G-CSF+ plerixafor mobilization in B-talassemia patients and whole gene expression analysis of the harvested CD34+ cell"

2014

G-CSF plerixafor CD34+ cell microarray
researchProduct

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators

2022

Background & aims: Activation of Kupffer cells and recruitment of monocytes are key events in fibrogenesis. These cells release soluble mediators which induce the activation of hepatic stellate cells (HSCs), the main fibrogenic cell type within the liver. Mer tyrosine kinase (MerTK) signaling regulates multiple processes in macrophages and has been implicated in the pathogenesis of non-alcoholic steatohepatitis-related fibrosis. In this study, we explored if MerTK activation in macrophages influences the profibrogenic phenotype of HSCs. Methods: Macrophages were derived from THP-1 cells or differentiated from peripheral blood monocytes towards MerTK+/CD206+/CD163+/CD209- macrophages. Th…

HepatologyCM conditioned medium ECM extracellular matrix Gas-6 Gas-6 growth arrest-specific gene 6 HSC(s) hepatic stellate cells KC(s) Kupffer cell(s) M-CSF macrophage colony-stimulating factor M2c-like macrophages MerTK Myeloid-epithelial-reproductive tyrosine kinase NAFLD non-alcoholic fatty liver disease NASH NASH non-alcoholic steatohepatitis PMA phorbol 12-myristate 13-acetate TGFβ1 transforming growth factor-β1 THP-1 TIMP1 tissue inhibitor of metalloproteinase 1 VEGF-A vascular endothelial growth factor-A liver fibrosis siRNA small-interfering RNAGas-6; liver fibrosis; M2c-like macrophages; NASH; THP-1GastroenterologyInternal MedicineImmunology and AllergyJHEP Reports
researchProduct

Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.

2020

Abstract Objective To assess the usefulness of the κ free light chain index (κFLCi) as a screening test to identify patients with suspected MS. Methods The study included 56 patients with a request to test for oligoclonal bands (OCBs). OCBs were detected by isoelectric focusing, followed by immunofixation. Cerebrospinal fluid (CSF) and serum κFLC were measured by a turbidimetric assay. Also, the κFLC index (κFLCi) was calculated. Results CSF κFLC levels and κFLCi were significantly higher in patients with multiple sclerosis (MS) than in patients with other neurological diseases (NDs; P < .001 and P < .001, respectively). At the cutoff value of 2.9, the κFLCi detected MS with s…

ImmunofixationAdultMale030213 general clinical medicinemedicine.medical_specialtyMultiple SclerosisScreening testClinical BiochemistryκFLCCSFfree light chainImmunoglobulin light chainGastroenterologySensitivity and Specificity03 medical and health sciences0302 clinical medicineCerebrospinal fluidInternal medicinemedicineHumansMass ScreeningAgedOCBbiologybusiness.industryIsoelectric focusingMultiple sclerosisBiochemistry (medical)Middle AgedκFLC indexmedicine.diseaseFree Light Chainmultiple sclerosibiology.proteinbiomarkerBiomarker (medicine)FemaleImmunoglobulin Light Chainsbusiness030217 neurology & neurosurgeryBiomarkersLaboratory medicine
researchProduct